Status: current, Defined. Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4963766018 | Pediatric hepatocellular carcinoma | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4963767010 | Childhood-onset hepatocellular carcinoma | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4963768017 | Pediatric hepatocellular carcinoma (disorder) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4963769013 | Paediatric hepatocellular carcinoma | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4963770014 | Childhood-onset HCC (hepatocellular carcinoma) | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 4963771013 | Pediatric HCC (hepatocellular carcinoma) | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 4963772018 | Paediatric HCC (hepatocellular carcinoma) | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 4963778019 | A rare aggressive malignant hepatic tumor arising from the hepatocytes. It develops mainly in children over 10 years of age, either in a cirrhotic background, or more commonly in a non-cirrhotic background. The main presenting manifestations are abdominal mass with pain, swelling and discomfort, weight loss, and anorexia. Splenomegaly, nausea, vomiting and jaundice are less commonly observed. Metastases to the mediastinal lymph nodes, lungs, brain and bone marrow are common in advanced disease May be associated with congenital diseases such as biliary atresia. The Wnt/beta-catenin pathway is frequently activated via stabilizing mutations in beta-catenin: some patients have been found to have mutations in the CTNNB1 (3p21) and MET (7q31) genes. TP53 (17p13.1) gene and the TERT promoter are mutated in 25-30% and 60% of cases respectively. | en | Definition | Active | Case sensitive | SNOMED CT core |
| 4963779010 | A rare aggressive malignant hepatic tumour arising from the hepatocytes. It develops mainly in children over 10 years of age, either in a cirrhotic background, or more commonly in a non-cirrhotic background. The main presenting manifestations are abdominal mass with pain, swelling and discomfort, weight loss, and anorexia. Splenomegaly, nausea, vomiting and jaundice are less commonly observed. Metastases to the mediastinal lymph nodes, lungs, brain and bone marrow are common in advanced disease May be associated with congenital diseases such as biliary atresia. The Wnt/beta-catenin pathway is frequently activated via stabilising mutations in beta-catenin: some patients have been found to have mutations in the CTNNB1 (3p21) and MET (7q31) genes. TP53 (17p13.1) gene and the TERT promoter are mutated in 25-30% and 60% of cases respectively. | en | Definition | Active | Case sensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Paediatric hepatocellular carcinoma | Is a | Liver cell carcinoma | true | Inferred relationship | Some | ||
| Paediatric hepatocellular carcinoma | Occurrence | Childhood | true | Inferred relationship | Some | 1 | |
| Paediatric hepatocellular carcinoma | Finding site | Liver structure | true | Inferred relationship | Some | 1 | |
| Paediatric hepatocellular carcinoma | Associated morphology | Hepatocellular carcinoma | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Clinical finding foundation reference set
Australian dialect reference set
Neoplasm and/or hamartoma reference set
Problem/Diagnosis reference set
Description inactivation indicator reference set
FHIR